Search - tctmd.com

Displaying 61 - 80 of 4915

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2025

Caitlin E. Cox

November 03, 2025

News Conference News TCT 2025

AI-ECG Finds STEMI Faster, Cuts False-Positive Cath Lab Activations

Todd Neale

October 31, 2025

News Conference News TCT 2025

PROCTOR: PCI of Failed Bypass Grafts Tops Native-Vessel PCI, With Caveats

Todd Neale

October 28, 2025

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

Presentation TCT 2025

TCT 498: Comparative Effectiveness of GLP-1 Receptor Agonists vs. SGLT2 Inhibitors on Cardiovascular Outcomes in Patients with Diabetes Undergoing Percutaneous Coronary Intervention

Presenter: Ahmed A. Mahmoud

October 28, 2025

Presentation TCT 2025

TCT 499: Impact of GLP-1 Agonists on Cardiovascular Outcomes in Obese Adults with HFrEF receiving Guideline Directed Medical Therapy: A Propensity Score Matched Analysis

Presenter: Dawood Shehzad

October 28, 2025

Presentation TCT 2025

TCT 492: Sodium-Glucose Co-Transporter 2 Inhibitors on Cardiovascular Outcomes Post-PCI in Patients with Diabetes: Findings from the TriNetX Database

Presenter: Aymen Ahmed

October 28, 2025

Presentation TCT 2025

TCT 488: Sex-Based Differences in Cardiovascular Outcomes With Achieved LDL-C <55 mg/dL: A Comparative Cohort Analysis

Presenter: Mehmet Cilingiroglu

October 28, 2025

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

Presentation TCT 2025

TCT 1206: Clinical Presentation and Long-Term Outcomes of Patients Without Standard Modifiable Cardiovascular Risk Factors: Insight from the DECADE Cooperation

Presenter: Claudio Laudani

October 27, 2025

Presentation TCT 2025

TCT 98: Elevated Calcium-Phosphate Product (CPP) is Independently Associated With Higher Cardiovascular Procedure Rates and Adverse Outcomes in Chronic Kidney Disease (CKD): A Propensity Score–Matched Analysis

Presenter: Muhammad Raffey Shabbir

October 27, 2025

Presentation TCT 2025

TCT 1003: Clinical Effectiveness of Glucagon-like peptide-1 receptor agonists on Cardiovascular outcomes Post-PCI in Type 2 Diabetes patients: Findings from the TriNetX Database

Presenter: Aymen Ahmed

October 27, 2025

Presentation TCT 2025

TCT 1004: Cardiovascular Outcomes of PCSK9 Inhibitor Use in Percutaneous Coronary Intervention

Presenter: Grant William Reed

October 27, 2025

Presentation TCT 2025

TCT 293: Ventricular Arrhythmias and in-hospital outcomes in Non-Elective Coronary Artery Bypass Graft in Type 1 Myocardial Infarction: An Analysis of the National Inpatient Sample

Presenter: Ben Thiravetyan

October 27, 2025

Presentation TCT 2025

TCT 1283: Clinical Presentation and Long-Term Outcomes of Patients Without Standard Modifiable Cardiovascular Risk Ffactors: Insight from the DECADE Cooperation

Presenter: Claudio Laudani

October 27, 2025

Presentation TCT 2025

TCT 534: Circulatory Assist Devices in HFrEF: Assessing 30-Day Major Adverse Cardiovascular Events and Clinical Outcomes

Presenter: Mohamed Elhussain

October 27, 2025

News Conference News TCT 2025

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Yael L. Maxwell

October 26, 2025

Presentation TCT 2025

TCT 554: Understanding the burden of multivalvular disease in patients with cardiomyopathy referred to cardiovascular magnetic resonance

Presenter: Davide Margonato

October 26, 2025

Presentation TCT 2025

TCT 303: Mortality Outcomes in STEMI Patients with CTO Undergoing PCI, CABG, or Medical Management

Presenter: Teja Sanjiv Chakrala

October 26, 2025

Presentation TCT 2025

TCT 776: Clinical Effectiveness of Sodium-Glucose Co-Transporter 2 Inhibitors on Cardiovascular and Limb Outcomes in Patients with Type 2 Diabetes and Peripheral Artery Disease: Findings from the TriNetX Database

Presenter: Aymen Ahmed

October 26, 2025

Advertisement

TCTMD’s Top 10 Most Popular Stories for October 2025

AI-ECG Finds STEMI Faster, Cuts False-Positive Cath Lab Activations

PROCTOR: PCI of Failed Bypass Grafts Tops Native-Vessel PCI, With Caveats

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

TCT 498: Comparative Effectiveness of GLP-1 Receptor Agonists vs. SGLT2 Inhibitors on Cardiovascular Outcomes in Patients with Diabetes Undergoing Percutaneous Coronary Intervention

TCT 499: Impact of GLP-1 Agonists on Cardiovascular Outcomes in Obese Adults with HFrEF receiving Guideline Directed Medical Therapy: A Propensity Score Matched Analysis

TCT 492: Sodium-Glucose Co-Transporter 2 Inhibitors on Cardiovascular Outcomes Post-PCI in Patients with Diabetes: Findings from the TriNetX Database

TCT 488: Sex-Based Differences in Cardiovascular Outcomes With Achieved LDL-C <55 mg/dL: A Comparative Cohort Analysis

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

TCT 1206: Clinical Presentation and Long-Term Outcomes of Patients Without Standard Modifiable Cardiovascular Risk Factors: Insight from the DECADE Cooperation

TCT 98: Elevated Calcium-Phosphate Product (CPP) is Independently Associated With Higher Cardiovascular Procedure Rates and Adverse Outcomes in Chronic Kidney Disease (CKD): A Propensity Score–Matched Analysis

TCT 1003: Clinical Effectiveness of Glucagon-like peptide-1 receptor agonists on Cardiovascular outcomes Post-PCI in Type 2 Diabetes patients: Findings from the TriNetX Database

TCT 1004: Cardiovascular Outcomes of PCSK9 Inhibitor Use in Percutaneous Coronary Intervention

TCT 293: Ventricular Arrhythmias and in-hospital outcomes in Non-Elective Coronary Artery Bypass Graft in Type 1 Myocardial Infarction: An Analysis of the National Inpatient Sample

TCT 1283: Clinical Presentation and Long-Term Outcomes of Patients Without Standard Modifiable Cardiovascular Risk Ffactors: Insight from the DECADE Cooperation

TCT 534: Circulatory Assist Devices in HFrEF: Assessing 30-Day Major Adverse Cardiovascular Events and Clinical Outcomes

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

TCT 554: Understanding the burden of multivalvular disease in patients with cardiomyopathy referred to cardiovascular magnetic resonance

TCT 303: Mortality Outcomes in STEMI Patients with CTO Undergoing PCI, CABG, or Medical Management

TCT 776: Clinical Effectiveness of Sodium-Glucose Co-Transporter 2 Inhibitors on Cardiovascular and Limb Outcomes in Patients with Type 2 Diabetes and Peripheral Artery Disease: Findings from the TriNetX Database

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content